TL;DR
- Canary Capital sets up a Delaware trust for the “Staked INJ ETF,” marking the first step toward a potential ETF launch focused on Injective’s native token.
- The proposed INJ ETF aims to offer investors dual exposure, capturing price movements of INJ while providing staking rewards, a novel benefit in the ETF space.
- This initiative aligns with a growing trend for altcoin ETFs in the U.S. and signals strong institutional interest, pending regulatory review and necessary filings.
Canary Capital has gained attention by setting up a Delaware trust named “Canary Staked INJ ETF.” This step is the first official action towards potentially launching an ETF focused on Injective’s native token. Designed to offer exposure not only to the price movements of INJ but also to staking rewards, this innovative product may pave the way for mainstream investors to tap into DeFi income.
BREAKING: CANARY STAKED $INJ ETF REGISTERED IN DELAWARE 🚨
— Injective 🥷 (@injective) June 9, 2025
Breaking Ground for DeFi ETF Innovation
Canary Capital’s move follows a growing trend among asset managers seeking to bring altcoin-based ETFs to U.S. markets. By setting up a statutory trust in Delaware, the firm is laying the necessary groundwork required before submitting crucial filings with the SEC.
While the ultimate launch of the ETF remains subject to regulatory review and the completion of filings such as Form S-1 and Form 19b-4, this trust registration is viewed as a significant milestone. Industry observers note that similar strategies have been used in the past for other cryptocurrency-based products, suggesting that this initiative could be the first step toward a broader range of staked crypto ETFs.
How the Staked INJ ETF Works
The proposed ETF is designed to track the spot price of INJ while simultaneously generating staking rewards. Investors would gain exposure to both the token’s price appreciation and the income produced from staking, offering a dual benefit rarely seen in standard ETFs.
This structure may help align the incentives of long-term holders with the overall health of the Injective network. Moreover, the product is expected to be initially tailored for U.S.-based investors, potentially attracting a wave of institutional interest. With Injective emerging as a promising blockchain for scalable decentralized finance and innovative use cases like tokenizing real-world assets, the ETF could well become a benchmark for similar products down the line.
Market Implications and Investor Outlook
The registration of the “Canary Staked INJ ETF” signals growing confidence in crypto ETFs that incorporate staking rewards. Should the product gain regulatory approval, it may unlock new channels for traditional investors to access decentralized finance markets.
